72 (PB060): TYRA-300, an oral, FGFR3-selective inhibitor: Preliminary pharmacokinetic and pharmacodynamic analysis from SURF301, the multicenter open-label phase 1/2 study of TYRA-300 in advanced urothelial carcinoma and other solid tumors with activating FGFR3 alterations

72 (PB060): TYRA-300, an oral, FGFR3-selective inhibitor: Preliminary pharmacokinetic and pharmacodynamic analysis from SURF301, the multicenter open-label phase 1/2 study of TYRA-300 in advanced urothelial carcinoma and other solid tumors with activating FGFR3 alterations

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cancer (1990) 2024-10, Vol.211, p.114599, Article 114599
Hauptverfasser: Loriot, Y., Zhang, A., Hansen, A., Mantia, C., Boni, V., Weickhardt, A., Yu, E.Y., Robert, M., Iyer, G., Murtha, A., Owens, S., Suttle, B., Vandekerkhove, G., Wyatt, A., Gammon, G., Burn, T., Tran, B.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:0959-8049
DOI:10.1016/j.ejca.2024.114599